Driving diversity and accessibility in clinical trials starts at the community level

Discover how expanding access to clinical trials is less about mandates and more about trust, time and practical realities. As therapies become more precise, representation in clinical research becomes increasingly important to ensure treatments are relevant for the diverse populations they are meant to serve. Drawing on her experience as a physician working at the site level, Dr. Melissa Choi explores how sustained community engagement and patient-centered trial design can make research more representative and accessible.

In this article, you’ll learn how to drive diversity and accessibility in clinical trials through:

• Building Trust and Relationships at the Community Level
• Designing Participation Around Patients’ Lives
• What Participation Means for Patients
• Representation and Precision Medicine Go Hand in Hand

Learn how community-centered engagement and patient-first approaches can improve representation, participation and real-world relevance in clinical research.

Improve representation, participation and real-world relevance. Download the article.